RegDev expands to UAE through strategic partnership with Onyx BioPartners.

Onyx is a strategic scientific partner bringing science from concept to market through evidence-led strategy and operator mindset. RegDev has spent decades curating a global team of experts across pharmaceutical and biotechnology functional areas and has supported 128 NDA/BLA/MAA submissions.

“I am excited to be a part of this emerging market on the ground floor, laying a strong quality-centric foundation that will carry them through the drug development lifecycle. Onyx is the perfect partner to collaborate on the needs of the region.”- Sid Senroy, Founder and President of RegDev.

Both organizations are deeply rooted in global expertise and understand regional regulatory authorities regulations and guidances. Onyx will be RegDev’s on the ground partner, making connections and collaborating across the MENA region to bring regulatory, quality, and compliance expertise to further drug development and partner on new safe and effective treatments for patients.

“I’m thrilled to start working with the RegDev team to bring their expertise to the Middle East. We share a common goal – supporting public health, driving innovation, and accelerating the growth of emerging companies. RegDev’s depth in regulatory and quality is a strong fit for what GCC is building, and I have no doubt this collaboration will open new horizons for our clients.” – Sintija Ursulska, Founder and CEO of Onyx BioPartners.

RegDev/Onyx will be attending DUPHAT (25-27 August 2026). Hope to connect with you there!

Interested in learning more about our new partner? Please visit https://onyx-biopartners.com/.